Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Patent covers charged tamoxifen derivatives for cancer therapy

March 13, 2000

Novel dinoflagellate-produced macrolide is cytotoxic to leukemia cells

March 10, 2000

Novel antitumor antibiotic identified from Streptomyces strain

March 10, 2000

Immune Response assesses brain tumor vaccine in phase I trial

March 10, 2000

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

FDA grants fast track status to BNP-7787 for treating paclitaxel-induced neurotoxicity

March 10, 2000

MDM2 antisense inhibitor collaboration ended by Hybridon and Searle

March 10, 2000

Inducer of phenotypic reversion; isolation, structure and activity of new trichostatin

March 9, 2000

FDA grants fast track status to arsenic trioxide

March 9, 2000

Antitumor/antiallergic agents discovered at Teijin

March 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...